Esperion Therapeutics, Inc. (LON:0IIM)
London · Delayed Price · Currency is GBP · Price in USD 3.423
+0.012 (0.36%)
Feb 12, 2026, 4:59 PM GMT
Esperion Therapeutics Market Cap
Esperion Therapeutics has a market cap or net worth of 587.62 million as of February 12, 2026. Its market cap has increased by 90.20% in one year.
Market Cap
587.62M
Enterprise Value
960.94M
Revenue
226.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.42
Market Cap Chart
Since June 26, 2013, Esperion Therapeutics's market cap has increased from 137.93M to 587.62M, an increase of 326.03%. That is a compound annual growth rate of 12.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 597.03M | -7.76% |
| Dec 31, 2025 | 647.22M | 86.92% |
| Dec 31, 2024 | 346.25M | 29.71% |
| Dec 29, 2023 | 266.94M | -29.93% |
| Dec 30, 2022 | 380.99M | 68.53% |
| Dec 31, 2021 | 226.06M | -57.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.68B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| Oxford Biomedica | 998.08M |
| CVS Group | 977.97M |
| Spire Healthcare Group | 814.80M |
| Allergy Therapeutics | 718.55M |